Cargando…
The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients
The CRNDE gene seems to play an oncogenic role in cancers, though its exact function remains unknown. Here, we tried to assess its usefulness as a molecular prognostic marker in ovarian cancer. Based on results of our microarray studies, CRNDE transcripts were further analyzed by Real-Time qPCR-base...
Autores principales: | Szafron, Lukasz Michal, Balcerak, Anna, Grzybowska, Ewa Anna, Pienkowska-Grela, Barbara, Podgorska, Agnieszka, Zub, Renata, Olbryt, Magdalena, Pamula-Pilat, Jolanta, Lisowska, Katarzyna M., Grzybowska, Ewa, Rubel, Tymon, Dansonka-Mieszkowska, Agnieszka, Konopka, Bozena, Kulesza, Magdalena, Lukasik, Martyna, Kupryjanczyk, Jolanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791275/ https://www.ncbi.nlm.nih.gov/pubmed/26556866 |
Ejemplares similares
-
The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues
por: Szafron, Lukasz Michal, et al.
Publicado: (2015) -
The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome
por: Konopka, Bozena, et al.
Publicado: (2016) -
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2018) -
Gene Expression Analysis in Ovarian Cancer – Faults and Hints from DNA Microarray Study
por: Lisowska, Katarzyna Marta, et al.
Publicado: (2014) -
PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2022)